{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:01:07Z","timestamp":1771891267487,"version":"3.50.1"},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Die chronische Hyperkali\u00e4mie ist eine Elektrolytst\u00f6rung, die vor allem bei zunehmender Einschr\u00e4nkung der Nierenfunktion beobachtet wird. Sie entwickelt sich meist \u00fcber einen l\u00e4ngeren Zeitraum, und die Symptome sind h\u00e4ufig gering. Da eine chronische Hyperkali\u00e4mie mit einer erh\u00f6hten Morbidit\u00e4t und Mortalit\u00e4t assoziiert ist, sollte eine chronische Hyperkali\u00e4mie behandelt werden. Die Behandlung beginnt mit der \u00dcberpr\u00fcfung der Medikamente, die m\u00f6glicherweise f\u00fcr die Hyperkali\u00e4mie verantwortlich sind, und einer sorgf\u00e4ltigen Therapie und Korrektur des Stoffwechsels. Die Evaluation der Ern\u00e4hrung fokussiert heute auf die Aufnahme von Kalium aus nicht pflanzlichen Kaliumquellen. Von einer Dosisreduktion und\/oder dem Absetzen von Renin-Angiotensin-Aldosteron-Hemmern sollte abgesehen werden, da diese Medikamente die Prognose bei Patienten mit Herzinsuffizienz und proteinurischer Nierenerkrankung verbessern. Zus\u00e4tzlich zu anderen konservativen Ma\u00dfnahmen sollten moderne Kalium-bindende Substanzen eingesetzt werden.<\/jats:p>","DOI":"10.1055\/a-2755-3785","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:57:02Z","timestamp":1768867022000},"page":"221-228","source":"Crossref","is-referenced-by-count":0,"title":["Paradigmenwechsel in der Behandlung der chronischen Hyperkali\u00e4mie zur Optimierung der kardiorenalen Prognose"],"prefix":"10.1055","volume":"151","author":[{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[{"name":"Universit\u00e4res Herzzentrum L\u00fcbeck, Medizinische Klinik II, Klinik f\u00fcr Kardiologie, Angiologie und Intensivmedizin, Universit\u00e4tsklinikum Schlesweig Holstein \u2013 Campus L\u00fcbeck, Deutschland"},{"name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung (DZHK), Standort Hamburg\/Kiel\/L\u00fcbeck, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insa","family":"Emrich","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum des Saarlandes, Klinik f\u00fcr Innere Medizin III, Homburg\/Saar, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kardiologie und Pneumologie, Universit\u00e4tsmedizin G\u00f6ttingen, Deutschland"},{"name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung e.V., Niedersachsen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Schle\u00df","sequence":"additional","affiliation":[{"name":"Hausarztpraxis und Kardiologische Praxis, Neu-Ulm, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin IV mit den Schwerpunkten Nieren - und Hochdruckkrankheiten, Christian-Albrechts-Universit\u00e4t, Kiel, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Strutz","sequence":"additional","affiliation":[{"name":"Nierenzentrum Wiesbaden und Deutsche Klinik f\u00fcr Diagnostik Helios, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Wassmann","sequence":"additional","affiliation":[{"name":"Herzpraxis Pasing, M\u00fcnchen, Deutschland"},{"name":"Medizinische Fakult\u00e4t, Universit\u00e4t Saarland, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"van der Giet","sequence":"additional","affiliation":[{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Medizinische Klinik f\u00fcr Nephrologie und Internistische Intensivtherapie, Berlin, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"CM Clase","year":"2020","journal-title":"Kidney international"},{"issue":"12","key":"ref2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jash.2017.09.011","article-title":"Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension","volume":"11","author":"CP Kovesdy","year":"2017","journal-title":"J Am Soc Hypertens"},{"issue":"04","key":"ref3","doi-asserted-by":"publisher","first-page":"F593","DOI":"10.1152\/ajprenal.00454.2003","article-title":"Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule","volume":"287","author":"P Meneton","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic","volume":"7","author":"PA Sarafidis","year":"2012","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"S 05","key":"ref5","first-page":"S1","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes Diabetes Work, G","year":"2022","journal-title":"Kidney Int"},{"issue":"S 04","key":"ref6","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes, C.K.D.W.G","year":"2024","journal-title":"Kidney Int"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"G Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"36","key":"ref8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction","volume":"10","author":"J Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"HL Hillege","year":"2006","journal-title":"Circulation"},{"issue":"07","key":"ref11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ndt\/gfae056","article-title":"Hyperkalemia treatment standard","volume":"39","author":"BF Palmer","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"17","key":"ref12","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis","volume":"39","author":"CP Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"e008912","DOI":"10.1161\/JAHA.118.008912","article-title":"Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study","volume":"7","author":"RW Thomsen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"R989","DOI":"10.1152\/ajpregu.1989.257.5.R989","article-title":"Renal potassium transport: morphological and functional adaptations","volume":"257","author":"BA Stanton","year":"1989","journal-title":"Am J Physiol"},{"issue":"01","key":"ref15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/path.1750","article-title":"Enhanced large intestinal potassium permeability in end-stage renal disease","volume":"206","author":"T Mathialahan","year":"2005","journal-title":"J Pathol"},{"issue":"06","key":"ref16","first-page":"516","article-title":"Renal complications associated with use of nonsteroidal anti-inflammatory agents","volume":"43","author":"BF Palmer","year":"1995","journal-title":"J Investig Med"},{"issue":"06","key":"ref17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ki.1991.321","article-title":"Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease","volume":"40","author":"M Allon","year":"1991","journal-title":"Kidney Int"},{"issue":"01","key":"ref18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.34067\/KID.0000222019","article-title":"Potassium Homeostasis, Chronic Kidney Disease, and the Plant-Enriched Diets","volume":"1","author":"BF Palmer","year":"2020","journal-title":"Kidney 360"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"CM Clase","year":"2020","journal-title":"Kidney Int"},{"issue":"02","key":"ref20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2215\/CJN.08580718","article-title":"Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis","volume":"14","author":"VM Saglimbene","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/ndt\/gfad015","article-title":"Factors associated with kalemia in renal disease","volume":"38","author":"M Granal","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/nu16010003","article-title":"Re-Thinking Hyperkalaemia Management in Chronic Kidney Disease-Beyond Food Tables and Nutrition Myths: An Evidence-Based Practice Review","volume":"16","author":"HL MacLaughlin","year":"2023","journal-title":"Nutrients"},{"issue":"03","key":"ref23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajcnut.2024.06.025","article-title":"Plant-based diet in hyperkalemic chronic kidney disease patients receiving sodium zirconium cyclosilicate: a feasibility clinical trial","volume":"120","author":"CM Avesani","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"05","key":"ref24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.7326\/M22-2904","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","author":"P Rossing","year":"2022","journal-title":"Kidney International"},{"issue":"S 11","key":"ref25","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"M Epstein","year":"2015","journal-title":"Am J Manag Care"},{"issue":"02","key":"ref26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/j.ajkd.2022.01.002","article-title":"Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study","volume":"80","author":"SJ Leon","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/2054358120965838","article-title":"Polysulfonate Resins in Hyperkalemia: A Systematic Review","volume":"7","author":"SWS Wong","year":"2020","journal-title":"Can J Kidney Health Dis"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","article-title":"Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age","volume":"179","author":"JA Noel","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"DA Bushinsky","year":"2015","journal-title":"Kidney Int"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"M Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.resuscitation.2021.02.011","article-title":"European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances","volume":"161","author":"C Lott","year":"2021","journal-title":"Resuscitation"},{"issue":"04","key":"ref32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns","volume":"105","author":"A Levin","year":"2024","journal-title":"Kidney Int"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study","volume":"14","author":"BS Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial","volume":"314","author":"GL Bakris","year":"2015","journal-title":"JAMA"},{"issue":"03","key":"ref35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2215\/CJN.0000000000000300","article-title":"SGLT2 Inhibition and Kidney Potassium Homeostasis","volume":"19","author":"BF Palmer","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"ref36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCULATIONAHA.121.057736","article-title":"Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials","volume":"145","author":"BL Neuen","year":"2022","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110239","article-title":"Effect of sodium-glucose co-transporter 2 inhibitors on plasma potassium: A meta-analysis","volume":"196","author":"C Charlwood","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes","volume":"393","author":"R Agarwal","year":"2025","journal-title":"N Engl J Med"},{"issue":"41","key":"ref39","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"J Butler","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2024.11.014","article-title":"Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure","volume":"85","author":"MN Kosiborod","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2755-3785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:30:33Z","timestamp":1771889433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2755-3785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":40,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2755-3785","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}